BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Metastatic Breast Cancer Alliance - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.mbcalliance.org
X-WR-CALDESC:Events for Metastatic Breast Cancer Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190322T080000
DTEND;TZID=America/New_York:20190322T160000
DTSTAMP:20260501T073016
CREATED:20190208T170447Z
LAST-MODIFIED:20190212T172430Z
UID:10000628-1553241600-1553270400@www.mbcalliance.org
SUMMARY:FDA-NBTS Public Workshop: Product Development for Central Nervous System Metastases
DESCRIPTION:Co-Sponsored by the: U.S. Food & Drug Administration (FDA) and the National Brain Tumor Society (NBTS) \nIn collaboration with: Accelerate Brain Cancer Cure (ABC2); American Brain Tumor Association (ABTA); Friends of Cancer Research (FOCR); Kidney Cancer Research Alliance (KCCure); LUNGevity Foundation; Melanoma Research Alliance (MRA); Metastatic Breast Cancer Alliance (MBC Alliance); RANO (Response Assessment in Neuro-Oncology) and Society for NeuroOncology (SNO) \nThere is a paucity of effective treatments for patients with central nervous system (CNS) metastases. Moreover\, there are few clinical trials and a need for more attention to this high unmet medical need. One impediment to product development for CNS metastases is uncertainty on the optimal clinical trial endpoints and study designs for evaluating products. This unique workshop will bring key stakeholders together to evaluate what is needed to advance development of effective products and consider optimal endpoints and clinical trial designs related to this topic. \nLocation: FDA White Oak Campus\nBuilding 31\, Room 1503 – Great Room\n10903 New Hampshire Avenue\nSilver Spring\, MD 20993 \nPersons interested in attending this public workshop must register online by 5 PM on March 20\, 2019. \nIf you need special accommodations due to a disability\, please contact Joan Todd before 5:00 PM\, EST\, March 7\, 2019. \n[maxbutton id=”41″ url=”https://www.eventbrite.com/e/product-development-for-central-nervous-system-cns-metastases-public-workshop-tickets-53818045222″ text=”Click HERE to Learn More & Register” ]
URL:https://www.mbcalliance.org/event/fda-nbts-public-workshop-product-development-for-central-nervous-system/
LOCATION:FDA White Oak Campus\, 10903 New Hampshire Ave\, Silver Spring\, MD\, 20993
CATEGORIES:WORKSHOPS
ATTACH;FMTTYPE=image/jpeg:https://www.mbcalliance.org/wp-content/uploads/https___cdn.evbuc_.com_images_54051207_261235303576_1_original.jpg
END:VEVENT
END:VCALENDAR